Asta Funding Inc (ASFI) 10.97 $ASFI Asta Funding Up

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Asta Funding Inc (ASFI) 10.97 $ASFI

Asta Funding Up 34.4% Since SmarTrend Uptrend Call (ASFI)
Comtex SmarTrend(R) - Mon Aug 01, 1:26PM CDT
SmarTrend identified an Uptrend for Asta Funding (NASDAQ:ASFI) on March 3rd, 2016 at $8.11. In approximately 5 months, Asta Funding has returned 34.40% as of today's recent price of $10.90.
ASFI: 10.97 (+0.13)

Asta Funding Has Returned 33.3% Since SmarTrend Recommendation (ASFI)
Comtex SmarTrend(R) - Fri Jul 15, 1:21AM CDT
SmarTrend identified an Uptrend for Asta Funding (NASDAQ:ASFI) on March 3rd, 2016 at $8.11. In approximately 4 months, Asta Funding has returned 33.29% as of today's recent price of $10.81.
ASFI: 10.97 (+0.13)

CBC Settlement Funding Completes BBRVI 2016-A Private Placement Note Offering
GlobeNewswire - Mon Jul 11, 4:12PM CDT
CBC Settlement Funding, LLC ("CBC", a diversified consumer financial services company, is pleased to announce the completion of its sixth private placement note offering on July 8, 2016. These notes are collateralized by payments stemming from rights arising under court ordered structured settlements, court ordered lottery payments, and single premium investment annuities originated by CBC Settlement Funding, LLC.
ASFI: 10.97 (+0.13)

Asta Funding Has Returned 28.2% Since SmarTrend Recommendation (ASFI)
Comtex SmarTrend(R) - Wed Jun 15, 1:06AM CDT
SmarTrend identified an Uptrend for Asta Funding (NASDAQ:ASFI) on March 3rd, 2016 at $8.11. In approximately 3 months, Asta Funding has returned 28.24% as of today's recent price of $10.40.
ASFI: 10.97 (+0.13)

Uptrend Call Working As Asta Funding Stock Rises 30.2% (ASFI)
Comtex SmarTrend(R) - Tue Jun 07, 1:42PM CDT
SmarTrend identified an Uptrend for Asta Funding (NASDAQ:ASFI) on March 3rd, 2016 at $8.11. In approximately 3 months, Asta Funding has returned 30.21% as of today's recent price of $10.56.
ASFI: 10.97 (+0.13)

Shares of ASFI Up 29.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue May 31, 1:03AM CDT
SmarTrend identified an Uptrend for Asta Funding (NASDAQ:ASFI) on March 3rd, 2016 at $8.11. In approximately 3 months, Asta Funding has returned 29.22% as of today's recent price of $10.48.
ASFI: 10.97 (+0.13)

Asta Funding, Inc. Announces Final Results of Its Modified Dutch Auction Tender Offer
GlobeNewswire - Fri May 13, 8:00AM CDT
Asta Funding, Inc. (NASDAQ:ASFI) ("Asta" or the "Company" today announced the final results of its modified "Dutch auction" tender offer, which expired at 5:00 p.m., New York City Time, on May 12, 2016. The Company will purchase 274,185 shares of its common stock at a purchase price of $10.25 per share, for an aggregate purchase price of $2,810,396.25, excluding fees and expenses relating to the tender offer.
ASFI: 10.97 (+0.13)

Asta Funding Up 26.3% Since SmarTrend Uptrend Call (ASFI)
Comtex SmarTrend(R) - Fri May 13, 12:30AM CDT
SmarTrend identified an Uptrend for Asta Funding (NASDAQ:ASFI) on March 3rd, 2016 at $8.11. In approximately 2 months, Asta Funding has returned 26.26% as of today's recent price of $10.24.
ASFI: 10.97 (+0.13)

Asta Funding reports 2Q loss
Automated Insights - Tue May 10, 3:19PM CDT
ENGLEWOOD CLIFFS, N.J. (AP) _ Asta Funding Inc. (ASFI) on Tuesday reported a fiscal second-quarter loss of $1.8 million, after reporting a profit in the same period a year earlier.
ASFI: 10.97 (+0.13)

Asta Funding, Inc. Announces Financial Results for the Second Quarter and First Six Months of Fiscal 2016
GlobeNewswire - Tue May 10, 3:00PM CDT
-- Total Income $23.3 million for the Six Months, an increase of 10% over the prior year
ASFI: 10.97 (+0.13)

Asta Funding, Inc. Announces Clarifying Amendment of Its Tender Offer to Purchase Up to 3,000,000 Shares of Its Common Stock
GlobeNewswire - Tue May 03, 3:45PM CDT
Asta Funding, Inc. (NASDAQ:ASFI) ("Asta" or the "Company" announced today that it had filed with the Securities and Exchange Commission certain amendments to its modified "Dutch auction" self-tender offer which commenced on April 11, 2016. The amendment does not change any of the economic terms of the Company's Offer to Purchase (the "Offer", which is structured as a Dutch auction with a price range of $9.50-$10.25 per share and an expiration date of May 12, 2016. The amendment updates the Offer to reflect the termination of the tender offer of MPF InvestCo 4, LLC, a Delaware limited liability company which is a direct, wholly owned subsidiary of The Mangrove Partners Master Fund, Ltd. In addition, the amendment provides clarification of certain other information contained in the Offer, including to:
ASFI: 10.97 (+0.13)

Mangrove Announces Termination of Tender Offer for Shares of Common Stock of Asta Funding, Inc.
PR Newswire - Tue Apr 26, 4:22PM CDT
Mangrove Partners ("Mangrove" today announced that it has terminated the previously announced cash tender offer to acquire 3,000,000 shares of common stock of Asta Funding, Inc. ("ASTA" at an offering price of $9.50 per share. The tender offer was due to expire at 5:00 pm New York City Time on Monday, May 9, 2016.
ASFI: 10.97 (+0.13)

Asta Funding, Inc.'s Board of Directors Reaffirms Recommendation that Shareholders Reject Amended Unsolicited Tender Offer
GlobeNewswire - Thu Apr 21, 11:50AM CDT
Asta Funding, Inc. (NASDAQ:ASFI) ("Asta" or the "Company" today announced that its Board of Directors, after careful consideration of the amendment to the unsolicited tender offer announced by MPF Investco 4, LLC's, a direct, wholly-owned subsidiary of The Mangrove Partners Master Fund, Ltd. ("Mangrove", unanimously reaffirmed its recommendation to shareholders that they reject the unsolicited tender offer, as it is not in the best interests of the Company's shareholders.
ASFI: 10.97 (+0.13)

Mangrove Announces Increase of Purchase Price and Extension of Expiration Date of Tender Offer of Asta Funding, Inc.
PR Newswire - Fri Apr 15, 1:55PM CDT
Mangrove Partners ("Mangrove" today announced that it has increased the offering price of its previously announced tender offer of 3,000,000 shares of Asta Funding, Inc. (NASDAQ: ASFI) (ASTA) from $9.00 to $9.50, net to the seller in cash, less any applicable withholding taxes and without interest, upon the terms and subject to the conditions described in Mangrove's original offer to purchase filed with the SEC on March 22, 2016, and a supplement to the original offer to purchase and the related amended letter of transmittal, each to be filed with the SEC today. In connection with the increased purchase price, Mangrove has extended the expiration of the tender offer to 5:00 p.m. New York City time on Monday, May 9, 2016. The tender offer was originally scheduled to expire at 12:00 midnight, New York City time, on April 18, 2016.
ASFI: 10.97 (+0.13)

Uptrend Call Working As Asta Funding Stock Rises 23.7% (ASFI)
Comtex SmarTrend(R) - Tue Apr 12, 12:21AM CDT
SmarTrend identified an Uptrend for Asta Funding (NASDAQ:ASFI) on March 3rd, 2016 at $8.11. In approximately 1 month, Asta Funding has returned 23.67% as of today's recent price of $10.03.
ASFI: 10.97 (+0.13)

Asta Funding, Inc. Announces Commencement of Tender Offer to Purchase Up to 3,000,000 Shares of Its Common Stock
GlobeNewswire - Mon Apr 11, 2:19PM CDT
Asta Funding, Inc. (NASDAQ:ASFI) ("Asta" or the "Company" announced today the commencement of a modified "Dutch auction" self-tender offer to purchase for cash up to 3,000,000 shares of its common stock at a price per share not greater than $10.25 nor less than $9.50, less applicable withholding taxes and without interest. The NASDAQ closing price of Asta's common stock on April 8, 2016 was $10.00 per share.
ASFI: 10.97 (+0.13)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gwen Stefani Kicks Off OCVIBE's New Concert Hall

Updated Category News Views 101

A Homecoming Steeped in Nostalgia Orange County’s about to do a serious throwback, folks! Gwen Stefani is set to headline the opening concert at OCVIBE's spanking new concert hall in Anaheim on March 17, 2027. Curious choice for their opener? Hardly. This gal's practically woven into the county’s tapestry—her roots run deep here, enough to make even the casual music...

Continue Reading
Disney+ Teams Up with Tiff's: Blue Cookie Debut

Updated Category News Views 10

A Sweet Collaboration on the Horizon If somebody had told me that cookies could conjure up excitement equivalent to a TV show's new season, I'd have laughed. But here we are—Disney+ and Tiff's Treats are cooking up a storm with blue chocolate chip cookies to celebrate 'Percy Jackson and the Olympians' Season 3 premiere. The Cookie That Packs a Punch Forget ordinary...

Continue Reading
2GenPen's Patent Push: Transforming Credit Analysis

Updated Category News Views 111

Changing the Game in Credit Analysis When you hear about a company snagging a patent, it's usually a big whoop-de-do; but 2GenPen's latest achievement is making some serious waves. This isn't some 'pat-yourself-on-the-back' sort of news – it's got teeth in the world of finance. These folks just locked down their second U.S. patent, number 12,784,096, and it's all about...

Continue Reading
Tigo Energy Faces Lawsuit: Key Details for Investors

Updated Category News Views 49

Tigo Energy Inc.'s Troubles: A Stock Drop and Legal Woes You see, not every day do you wake up to find your investment taking a nose dive by 36.76%. But that’s exactly what happened to Tigo Energy, Inc. (NASDAQ: TYGO) after some shaky announcements. A Rollercoaster for Investors On August 4, 2026, Tigo hit investors with a one-two punch: revised financial outlook and...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 19

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 234

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Life Insurance: Evolving with Your Financial Journey

Updated Category News Views 32

Why Life Insurance Isn't Just a 'Set It and Forget It' Life insurance isn't some one-time deal you lock in and toss aside. Mike Newell, an insurance pro, highlights how life's shifts—whether in income, dependents, or debt—should drive tweaks to your coverage. As your life story unfolds, so too should the backbone of your financial security. Early Adulthood: Setting...

Continue Reading
Sinch Appoints Jonas Dahlberg as New CEO: A Strategic Move

Updated Category News Views 0

A Change at the Helm: Dahlberg Takes Charge Here we go, folks—Sinch, that global powerhouse in customer communications, just got itself a new captain. Jonas Dahlberg is now officially the CEO, after warming the acting CEO seat since June. This ain't your ordinary office shuffle. It's a calculated chess move in the high-stakes tech world. Dahlberg's Path to the Top This...

Continue Reading
LONGWELL's New Axial Fan Selection Guide Unveiled

Updated Category News Views 75

LONGWELL's New Fan Brochure Shakes Up Data Center Cooling Alright, let's cut to the chase. LONGWELL, the folks out in Ningbo who live and breathe HVACR and industrial fans, have dropped a new tool that’s going to have OEM engineers raising a glass. This twelve-page axial fan selection guide is a stroke of genius—or at least that's what those of us who've braved the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 162

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles